retatrutide dosage phase 2 trial VisualAbstract: reduces body weight by 17.5% in patients with obesity I get this question pretty

The clinics official page lists orforglipron, a once-daily oral GLP-1, is shown as coming soon

Bottom line: GLP-1 patches may contain recognisable ingredients, but there is currently no strong evidence that those ingredients are absorbed through the skin in amounts sufficient to support the effects claimed

This prevents contamination and preserves the integrity of the remaining solution

The Danish drugmaker also said it was aware of numerous studies looking at GLP-1s and reduction in addiction-related behaviors and welcomes independent research in this area

For a detailed comparison, see retatrutide vs

Diabetes Care 45(11):27532786